Details for New Drug Application (NDA): 017892
✉ Email this page to a colleague
The generic ingredient in HALCION is triazolam. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the triazolam profile page.
Summary for 017892
Tradename: | HALCION |
Applicant: | Pfizer |
Ingredient: | triazolam |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 017892
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
HALCION | triazolam | TABLET;ORAL | 017892 | NDA | Pharmacia & Upjohn Company LLC | 0009-0017 | 0009-0017-55 | 100 BLISTER PACK in 1 CARTON (0009-0017-55) / 1 TABLET in 1 BLISTER PACK |
HALCION | triazolam | TABLET;ORAL | 017892 | NDA | Pharmacia & Upjohn Company LLC | 0009-0017 | 0009-0017-58 | 10 TABLET in 1 BOTTLE (0009-0017-58) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.25MG | ||||
Approval Date: | Nov 15, 1982 | TE: | AB | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.5MG | ||||
Approval Date: | Nov 15, 1982 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.125MG | ||||
Approval Date: | Apr 26, 1985 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 017892
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | HALCION | triazolam | TABLET;ORAL | 017892-001 | Nov 15, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | HALCION | triazolam | TABLET;ORAL | 017892-001 | Nov 15, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | HALCION | triazolam | TABLET;ORAL | 017892-002 | Nov 15, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription